MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-MH-18-0074079
Agresco Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹68.35 Lakh
▼ 13% YoY
Net profit · FY 2025
₹21,500
Net margin 0.3%
EBITDA · FY 2025
₹34,355
EBITDA margin 0.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Agresco Pharma Private Limited
Data last updated:
Agresco Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 July 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC311584. Its GSTIN is 27AARCA0982F1ZG (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sanjay Kumar Patyal and Pankaj Narendra Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/22 Mangal Krupa Chs Ltd Appapada Malad (East) Near Lokhandwala, Mumbai, Maharashtra, India – 400097.
As per the financials filed for FY 2025, the company reported a revenue of ₹68.35 Lakh, a decline of 13% compared to the previous year. For the same year it recorded a net profit of ₹21,500 (net margin 0.3%) and EBITDA of ₹34,355 (EBITDA margin 0.5%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 33% over five years.
Agresco Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0074079). For more details, the company can be reached via its website agrescopharma.com.
Company details
CIN U74999MH2018PTC311584
Registration Number 311584
Incorporation Date 05 July 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-18-0074079
Recognitions & Rankings of Agresco Pharma
Contact details
Agresco Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is agrescopharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressC/22 Mangal Krupa Chs Ltd Appapada Malad (East) Near Lokhandwala, Mumbai, Maharashtra, India – 400097
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Agresco Pharma Private Limited, buy the company report.
Comprehensive company report
Agresco Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Agresco Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Agresco Pharma Private Limited, buy the company report.
Financials of Agresco Pharma Private Limited
FY 2025 filings availableAgresco Pharma Private Limited reported revenue of ₹68.35 Lakh (down 13% YoY) for FY 2025.
Revenue · FY 2025
₹68.35 Lakh ▼ 13%
Net profit · FY 2025
₹21,500 margin 0.3%
EBITDA · FY 2025
₹34,355 margin 0.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 13%
3 years · compounded
▲ 11%
5 years · compounded
▲ 33%
EBITDA CAGR growth
1 year
▲ 22%
3 years · compounded
▼ 49%
5 years · compounded
▲ 16%
Revenue fell 13% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 33%. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹34,355 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21,500 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Agresco Pharma Private Limited, buy the company report.
Board of directors of Agresco Pharma Private Limited
Agresco Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Kumar Patyal | Director | 05 Jul 2018 | 8 Years 3 Months | Current |
| Pankaj Narendra Yadav | Director | 05 Jul 2018 | 8 Years 3 Months | Current |
Auditor
Agresco Pharma Private Limited is audited by A D SONI & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A D SONI & CO | FY 2021 | 139835W |
Shareholding
The shareholding of Agresco Pharma Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Agresco Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Agresco Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Agresco Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Agresco Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AARCA0982F1ZG | Maharashtra | Active | 31 Jan 2019 |
To see the full GST registrations and return filing status of Agresco Pharma Private Limited, buy the company report.
Recent activity
Agresco Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Pankaj Narendra Yadav was appointed as Director on 05 Jul 2018.
AGM
Agresco Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Agresco Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Pankaj Narendra Yadav was appointed as Director.
Appointed
Sanjay Kumar Patyal was appointed as Director.
Incorporation
05 Jul 2018
Agresco Pharma Private Limited was registered on 05 Jul 2018 with Roc Mumbai I & aged 8 years 4 months as per MCA records.
Frequently asked questions
Agresco Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 July 2018 (8+ years old) and is registered under CIN U74999MH2018PTC311584.
Agresco Pharma has 2 current directors:
- Sanjay Kumar Patyal - Director
- Pankaj Narendra Yadav - Director
The latest financial statements of Agresco Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Agresco Pharma is 27AARCA0982F1ZG, registered in Maharashtra.
The CIN (Corporate Identification Number) of Agresco Pharma is U74999MH2018PTC311584. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Agresco Pharma was incorporated on 05 July 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Pankaj Narendra Yadav was appointed as Director on 05 Jul 2018. Sanjay Kumar Patyal was appointed as Director on 05 Jul 2018.
Yes, Agresco Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-18-0074079).
Agresco Pharma can be reached through the website agrescopharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Agresco Pharma is at C22 Mangal Krupa Chs Ltd Appapada Malad East Near Lokhandwala, Mumbai, Maharashtra, India – 400097.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages